• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

接种阿斯利康新冠疫苗后出现疱疹样皮肤病变：一例报告。

Herpes-like skin lesion after AstraZeneca vaccination for COVID-19: A case report.

作者信息

Ardalan Mohammadreza, Moslemi Hamidreza, Shafiei Shervin, Tabrizi Reza, Moselmi Mohammadreza

机构信息

Kidney Research Center Tabriz University of Medical Sciences Tabriz Iran.

Postgraduate Student of Oral and Maxillofacial Surgery Department of Oral and Maxillofacial Surgery Dental School Shahid Beheshti University of Medical Sciences Tehran Iran.

出版信息

Clin Case Rep. 2021 Oct 4;9(10):e04883. doi: 10.1002/ccr3.4883. eCollection 2021 Oct.

DOI:10.1002/ccr3.4883
PMID:34631069
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8489397/
Abstract

Recurrent herpes simplex virus or varicella zoster virus infection should be considered as one of the rare complications after AstraZeneca vaccination for COVID-19.

摘要

复发性单纯疱疹病毒或水痘带状疱疹病毒感染应被视为接种阿斯利康新冠疫苗后罕见的并发症之一。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bb87/8489397/263c65e738b3/CCR3-9-e04883-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bb87/8489397/b19dddf1d9db/CCR3-9-e04883-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bb87/8489397/263c65e738b3/CCR3-9-e04883-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bb87/8489397/b19dddf1d9db/CCR3-9-e04883-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bb87/8489397/263c65e738b3/CCR3-9-e04883-g003.jpg

相似文献

1
Herpes-like skin lesion after AstraZeneca vaccination for COVID-19: A case report.接种阿斯利康新冠疫苗后出现疱疹样皮肤病变：一例报告。
Clin Case Rep. 2021 Oct 4;9(10):e04883. doi: 10.1002/ccr3.4883. eCollection 2021 Oct.
2
Herpes zoster following vaccination with ChAdOx1 nCoV-19 Coronavirus vaccine (recombinant).接种 ChAdOx1 nCoV-19 冠状病毒疫苗（重组）后出现带状疱疹。
Indian J Public Health. 2022 Jan-Mar;66(1):83-85. doi: 10.4103/ijph.ijph_2017_21.
3
Herpes simplex virus retinitis following ChAdOx1 nCoV- 19 (Covishield) vaccination for SARS CoV 2: A case report.接种 ChAdOx1 nCoV-19（Covishield）疫苗后出现单纯疱疹病毒视网膜炎：1 例报告。
Ocul Immunol Inflamm. 2022 Jul;30(5):1282-1285. doi: 10.1080/09273948.2022.2069127. Epub 2022 May 19.
4
Herpes simplex encephalitis following ChAdOx1 nCoV-19 vaccination: a case report and review of the literature.接种 ChAdOx1 nCoV-19 疫苗后发生单纯疱疹病毒性脑炎：病例报告及文献复习。
BMC Infect Dis. 2022 Mar 3;22(1):217. doi: 10.1186/s12879-022-07186-9.
5
Cutaneous reactions after SARS-CoV-2 vaccination: a cross-sectional Spanish nationwide study of 405 cases.接种 SARS-CoV-2 疫苗后的皮肤反应：一项对 405 例病例的西班牙全国性横断面研究。
Br J Dermatol. 2022 Jan;186(1):142-152. doi: 10.1111/bjd.20639. Epub 2021 Sep 21.
6
Acute herpes zoster radiculopathy mimicking cervical radiculopathy after ChAdOx1 nCoV-19/AZD1222 vaccination.接种 ChAdOx1 nCoV-19/AZD1222 后酷似颈椎病的急性带状疱疹性神经根病。
BMJ Case Rep. 2022 Apr 22;15(4):e248943. doi: 10.1136/bcr-2022-248943.
7
Risk of thrombocytopenia and thromboembolism after covid-19 vaccination and SARS-CoV-2 positive testing: self-controlled case series study.新冠病毒疫苗接种后和 SARS-CoV-2 阳性检测后的血小板减少症和血栓栓塞风险：自身对照病例系列研究。
BMJ. 2021 Aug 26;374:n1931. doi: 10.1136/bmj.n1931.
8
Varicella zoster meningitis following COVID-19 vaccination: a report of two cases.接种 COVID-19 疫苗后出现带状疱疹性脑膜炎：两例报告。
Int J Infect Dis. 2022 Jun;119:214-216. doi: 10.1016/j.ijid.2022.03.055. Epub 2022 Mar 30.
9
Herpes Zoster Reactivation After mRNA and Adenovirus-Vectored Coronavirus Disease 2019 Vaccination: Analysis of National Health Insurance Database.mRNA 和腺病毒载体 COVID-19 疫苗接种后带状疱疹再激活：国家健康保险数据库分析。
J Infect Dis. 2023 Nov 11;228(10):1326-1335. doi: 10.1093/infdis/jiad297.
10
Herpesviruses reactivation following COVID-19 vaccination: a systematic review and meta-analysis.新冠病毒疫苗接种后疱疹病毒再激活：系统评价和荟萃分析。
Eur J Med Res. 2023 Aug 10;28(1):278. doi: 10.1186/s40001-023-01238-9.

引用本文的文献

1
A Study to Describe the Pattern of Cutaneous Adverse Effects of COVID-19 Vaccines (Covishield and Covaxin).一项描述新冠疫苗（Covishield和Covaxin）皮肤不良反应模式的研究。
Indian Dermatol Online J. 2023 Oct 13;14(6):814-820. doi: 10.4103/idoj.idoj_539_22. eCollection 2023 Nov-Dec.
2
Herpes Zoster and COVID-19 Vaccination: A Narrative Review.带状疱疹与新冠病毒疫苗接种：一篇叙述性综述
Clin Cosmet Investig Dermatol. 2023 Nov 16;16:3323-3331. doi: 10.2147/CCID.S441898. eCollection 2023.
3
Herpetic anterior uveitis following COVID-19 vaccines: a case series.

本文引用的文献

1
Herpes zoster following BNT162b2 mRNA COVID-19 vaccination in patients with autoimmune inflammatory rheumatic diseases: a case series.接受 BNT162b2 mRNA COVID-19 疫苗接种的自身免疫性炎症性风湿病患者的带状疱疹：病例系列。
Rheumatology (Oxford). 2021 Oct 9;60(SI):SI90-SI95. doi: 10.1093/rheumatology/keab345.
2
Adverse Events in Healthcare Workers after the First Dose of ChAdOx1 nCoV-19 or BNT162b2 mRNA COVID-19 Vaccination: a Single Center Experience.医护人员接种 ChAdOx1 nCoV-19 或 BNT162b2 mRNA COVID-19 疫苗第一针后出现的不良事件：单中心经验。
J Korean Med Sci. 2021 Apr 12;36(14):e107. doi: 10.3346/jkms.2021.36.e107.
3
新冠疫苗接种后疱疹性前葡萄膜炎：病例系列
Front Med (Lausanne). 2023 Sep 22;10:1242225. doi: 10.3389/fmed.2023.1242225. eCollection 2023.
4
Herpesviruses reactivation following COVID-19 vaccination: a systematic review and meta-analysis.新冠病毒疫苗接种后疱疹病毒再激活：系统评价和荟萃分析。
Eur J Med Res. 2023 Aug 10;28(1):278. doi: 10.1186/s40001-023-01238-9.
5
Global prevalence and clinical manifestations of cutaneous adverse reactions following COVID-19 vaccination: A systematic review and meta-analysis.新冠病毒疫苗接种后皮肤不良反应的全球流行率和临床表现：系统评价和荟萃分析。
J Eur Acad Dermatol Venereol. 2022 Nov;36(11):1947-1968. doi: 10.1111/jdv.18294. Epub 2022 Jun 21.
6
Herpes simplex encephalitis following ChAdOx1 nCoV-19 vaccination: a case report and review of the literature.接种 ChAdOx1 nCoV-19 疫苗后发生单纯疱疹病毒性脑炎：病例报告及文献复习。
BMC Infect Dis. 2022 Mar 3;22(1):217. doi: 10.1186/s12879-022-07186-9.
7
Potential risk factors for Varicella-zoster virus reactivation after COVID-19 vaccination.新冠病毒疫苗接种后水痘-带状疱疹病毒再激活的潜在风险因素。
J Cosmet Dermatol. 2022 Apr;21(4):1347-1349. doi: 10.1111/jocd.14871. Epub 2022 Feb 25.
8
SARS-CoV-2 vaccine-related cutaneous manifestations: a systematic review.SARS-CoV-2 疫苗相关皮肤表现：系统综述。
Int J Dermatol. 2022 Oct;61(10):1187-1204. doi: 10.1111/ijd.16063. Epub 2022 Feb 9.
T cell and antibody responses induced by a single dose of ChAdOx1 nCoV-19 (AZD1222) vaccine in a phase 1/2 clinical trial.
在一项 1/2 期临床试验中，单次接种 ChAdOx1 nCoV-19（AZD1222）疫苗诱导的 T 细胞和抗体反应。
Nat Med. 2021 Feb;27(2):270-278. doi: 10.1038/s41591-020-01194-5. Epub 2020 Dec 17.
4
Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK.ChAdOx1 nCoV-19 疫苗（阿斯利康）对 SARS-CoV-2 的安全性和有效性：巴西、南非和英国四项随机对照试验的中期分析。
Lancet. 2021 Jan 9;397(10269):99-111. doi: 10.1016/S0140-6736(20)32661-1. Epub 2020 Dec 8.
5
Herpes simplex virus and cytomegalovirus reactivations among severe COVID-19 patients.重症 COVID-19 患者中单纯疱疹病毒和巨细胞病毒的再激活
Crit Care. 2020 Aug 28;24(1):530. doi: 10.1186/s13054-020-03252-3.
6
Comment on: "To consider varicella-like exanthem associated with COVID-19, virus varicella zoster and virus herpes simplex must be ruled out. Characterization of herpetic lesions in hospitalized COVID-19 patients".评论：“对于考虑与COVID-19相关的水痘样皮疹，必须排除水痘带状疱疹病毒和单纯疱疹病毒。住院COVID-19患者疱疹性病变的特征”
J Am Acad Dermatol. 2020 Sep;83(3):e257-e259. doi: 10.1016/j.jaad.2020.06.063. Epub 2020 Jun 22.
7
Disarming Cellular Alarm Systems-Manipulation of Stress-Induced NKG2D Ligands by Human Herpesviruses.解除细胞警报系统——人类疱疹病毒对应激诱导的NKG2D配体的操控
Front Immunol. 2017 Apr 11;8:390. doi: 10.3389/fimmu.2017.00390. eCollection 2017.
8
Herpes simplex virus infection downmodulates NKG2D ligand expression.单纯疱疹病毒感染下调NKG2D配体的表达。
Scand J Immunol. 2009 May;69(5):429-36. doi: 10.1111/j.1365-3083.2009.02241.x. Epub 2009 Feb 26.
9
NKG2D ligands in tumor immunity.肿瘤免疫中的NKG2D配体
Oncogene. 2008 Oct 6;27(45):5944-58. doi: 10.1038/onc.2008.272.
10
NKG2D ligands: key targets of the immune response.NKG2D配体：免疫反应的关键靶点。
Trends Immunol. 2008 Aug;29(8):397-403. doi: 10.1016/j.it.2008.04.007. Epub 2008 Jul 3.